BioVision Antibodies
Anti-CD20 (Rituximab), Chimeric Antibody
- SKU:
- A1049-100
Description
Anti-CD20 (Rituximab), Chimeric Antibodyis available at Gentaur for Next week Delivery.
Description: Rituximab, a chimeric monoclonal antibody targeted against the pan-B-cell marker CD20. Mechanisms of cell destruction that have been demonstrated to be activated by rituximab binding to CD20 include direct signaling of apoptosis, complement activation and antibody dependent cellular cytotoxicity. Rituximab is a mainstay in the therapy for a broad variety of B-cell malignancies.
Immunogen Sequence:CD20
Target Alternative Name:MabThra
Species Reactivities:Human
Tag Line:Monoclonal human IgG1 antibody against human CD20
Formulation:100 ug (2 mg/ml) of antibody in Phosphate buffered saline, pH 7.4.
Purification: human IgG1 was expressed in a human cell line. IgG was purified from CHO cell culture supernatant by protein A chromatography.
Application:Neutralization, ELISA
Positive Control:/
Application And Usages:Activation : 1-20 μg/ml; ELISA: 2μg/ml
Handling:The antibody solution should be gently mixed before use
Additional Information
Size: |
100 µg |
Antibody Target: |
CD20 |
Category: |
Human IgG monoclonal antibodies |
Host: |
Human/Mouse chimeric |
Antibody Type: |
Monoclonal |
Isotype: |
Human IgG1 |
Accession Number: |
NP_690605 |
Gene Id: |
54474 |
Concentration: |
2 mg/ml |
Appearance: |
Colourless liquid |
Form: |
Liquid |
Storage Condition: |
-20°C |
Shipping Condition: |
gel pack |
Shelf Life: |
12 months |
Country of Animal Origin: |
USA |
Country of Manufacture: |
USA |
Usage: |
For Research Use Only! Not to be used in humans |
Western Blot Verified: |
Not Verified |
Immunocytochemistry Verified: |
Not Verified |
Immunofluorescence Verified: |
Not Verified |
Immunoprecipitation Verified: |
Not Verified |
ELISA Verified: |
Not Verified |
ChIP Verified: |
Not Verified |
Dot Blot Verified: |
Not Verified |
Flow Cytometry Verified: |
Not Verified |